The worldwide spread of Crimean Congo hemorrhagic fever orthonairovirus and Q fever: risk factors and implications for control strategies of a zoonotic disease
Resumo
Abstract: Crimean Congo hemorrhagic fever (CCHF) orthonairovirus and Q fever are zoonotic infections. CCHF is the dominant tick borne viral infection among livestock, with a serious threat to humans as well. Wide host range and asymptomatic traits has made infection eradication difficult. In addition, low infectious dose of the virus has made it a highly pathogenic agent. CCHF is recognized as a threat to public health and public health services for its epidemic potential, high fatality rate (up to 40%), its potential for nosocomial outbreaks and difficulties in treatment, prevention and control. Q fever is also a serious health threating disease. Knowledge of causative agent (Coxiella burnetii) remains limited until today. The rate of CCHF and Q fever as zoonotic infections has remained high in most of regions worldwide. Hence implementation of accurate control strategies can help prevent its spread. Use of ticks’ repellants, control of livestock and wildlife movements and multinational policies are also essential in this regard. Noticeably, it is necessary to establish and empower the international surveillance fulfills to better predict, investigate and control these infectious diseases, improve the international public health infrastructure, develop enhanced international guidelines, and recommendations to improve the international capabilities toward restriction of disease outbreaks with adequate medical and scientific resources and expertise. To predict and monitor the CCHF and Q fever, regional rather than countrywide scale cooperation is necessary. Immigration/travel also remains an important factor influencing the spread of these agents.
Key words: Crimean Congo hemorrhagic fever, Q fever, Zoonoses, control strategies
Palavras-chave
Referências
AHMADKHANI, M.; ALESHEIKH, A.A.; KHAKIFIROUZ, S.; SALEHI-VAZIRI, M. Space-time epidemiology of Crimean-Congo hemorrhagic fever (CCHF) in Iran. Ticks and tick-borne diseases. 2018;9(2):207-16.
ASLAM, S.; LATIF, M.S.; DAUD, M.; RAHMAN, Z.U.; TABASSUM, B.; RIAZ, M.S. et al. Crimean‑Congo hemorrhagic fever: Risk factors and control measures for the infection abatement. Biomedical reports. 2016;4(1):15-20.
BOND, K.; VINCENT, G.; WILKS, C.; FRANKLIN, L.; SUTTON B.; STENOS, J. et al. One Health approach to controlling a Q fever outbreak on an Australian goat farm. Epidemiology & Infection. 2016;144(6):1129-41.
CHINIKAR, S.; GHIASI, S.M.; HEWSON, R.; MORADI, M.; HAERI, A. Crimean-Congo hemorrhagic fever in Iran and neighboring countries. Journal of clinical virology. 2010;47(2):110-4.
CONGER, N.G.; PAOLINO, K.M.; OSBORN, E.C.; RUSNAK, J.M.; GÜNTHER, S.; POOL, J. et al. Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009. Emerging infectious diseases. 2015;21(1):23.
CUTLER, S.J.; BOUZID, M.; CUTLER, R.R. Q fever. Journal of Infection. 2007;54(4):313-8.
CASALS, J. Antigenic similarity between the virus causing Crimean hemorrhagic fever and Congo virus. Proceedings of the Society for Experimental Biology and Medicine. 1969;131(1):233-6.
FENOLLAR, F.; FOURNIER, P.; RAOULT, D. Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection. Journal of clinical microbiology. 2004;42(11):4919-24.
EZATKHAH, M.; ALIMOLAEI, M.; KHALILI, M.; SHARIFI H. Seroepidemiological study of Q fever in small ruminants from Southeast Iran. Journal of infection and public health. 2015;8(2):170-6.
GREINER, AL.; MAMUCHISHVILI, N.; KAKUTIA, N.; STAUFFER, K.; GELEISHVILI, M.; CHITADZE, N. et al. Crimean-Congo hemorrhagic fever knowledge, attitudes, practices, risk factors, and Seroprevalence in rural Georgian villages with known transmission in 2014. PloS one. 2016;11(6):e0158049.
GWIDA, M.; EL-ASHKER, M.; KHAN, I. Q fever: a re-emerging disease. J Vet Sci Technol. 2012;3(5).
Investigation I. Management of Outbreaks and Incidents of Unusual Illnesses–A Guide for NHS Staff. Health Protection Agency (Version 3. 2004.
HAWMAN, D.W.; FELDMANN, H. Recent advances in understanding Crimean–Congo hemorrhagic fever virus. F1000Research. 2018;7.
HAWMAN, D.W; HADDOCK, E.; MEADE-WHITE, K.; WILLIAMSON, B.; HANLEY, P.W.; ROSENKE, K., et al. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice. Antiviral research. 2018;157:18-26.
HONARMAND, H.Q. Fever: an old but still a poorly understood disease. Interdisciplinary perspectives on infectious diseases. 2012;2012.
KHALILI M, SAKHAEE E. An update on a serologic survey of Q fever in domestic animals in Iran. The American journal of tropical medicine and hygiene. 2009;80(6):1031-2.
LEBLEBICIOGLU H, OZARAS R, SUNBUL M. Crimean-Congo hemorrhagic fever: A neglected infectious disease with potential nosocomial infection threat. American journal of infection control. 2017;45(7):815-6.
FLETCHER, T.E.; GULZHAN, A.; AHMETI, S.; AL-ABRI, S.S.; ASIK, Z.; ATILLA, A. et al. Infection prevention and control practice for Crimean-Congo hemorrhagic fever—A multi-center cross-sectional survey in Eurasia. PloS one. 2017;12(9):e0182315.
LEBLEBICIOGLU, H.; SUNBUL, M.; GUNER, R.; BODUR, H.; BULUT, C.; DUYGU, F. et al. Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002–2014: A multicentre retrospective cross-sectional study. Clinical microbiology and infection. 2016;22(4):387. e1-. e4.
MALTEZOU, H.C.; RAOULT, D. Q fever in children. The Lancet infectious diseases. 2002;2(11):686-91.
OESTEREICH, L.; RIEGER, T.; NEUMANN, M.; BERNREUTHER, C.; LEHMANN, M.; KRASEMANN, S. et al. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever. PLoS neglected tropical diseases. 2014;8(5):e2804.
ORGANIZATION, W.H. Crimean-Congo Hemorrhagic Fever reported in Afghanistan, 2017. 2017 17 December 2017;10(51).
PALOMAR, A.M.; PORTILLO, A.; SANTIBÁÑEZ, S.; GARCÍA-ÁLVAREZ, L.; MUÑOZ-SANZ, A.; MÁRQUEZ, F.J. et al. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013–2015. Enfermedades infecciosas y microbiologia clinica. 2017;35(6):344-7.
PANAYOTOVA, E.; PAPA, A.; TRIFONOVA, I.; CHRISTOVA, I. Crimean-Congo hemorrhagic fever virus lineages Europe 1 and Europe 2 in Bulgarian ticks. Ticks and tick-borne diseases. 2016;7(5):1024-8.
PAPA, A.; BINO, S.; VELO, E.; HARXHI, A.; KOTA, M.; ANTONIADIS, A. Cytokine levels in Crimean-Congo hemorrhagic fever. Journal of clinical virology. 2006;36(4):272-6.
PAPA, A.; TSERGOULI, K.; TSIOKA, K.; MIRAZIMI, A. Crimean-congo hemorrhagic fever: tick-host-virus interactions. Frontiers in Cellular and Infection Microbiology. 2017;7:213.
PARKER, N.R.; BARRALET, J.H.; BELL, A.M. Q fever. The Lancet. 2006;367(9511):679-88.
PELLERIN, J.; ALSALEH, A.; MERMILLOD, P.; SOUZA-FABJAN, J.; RODOLAKIS, A.; ROUSSET, E. et al. Attachment of Coxiella burnetii to the zona pellucida of in vitro produced goat embryos. Theriogenology. 2018;106:259-64.
REHMAN, A.; NIJHOF, A.M.; SAUTER-LOUIS, C.; SCHAUER, B.; STAUBACH, C.; CONRATHS, F.J. Distribution of ticks infesting ruminants and risk factors associated with high tick prevalence in livestock farms in the semi-arid and arid agro-ecological zones of Pakistan. Parasites & vectors. 2017;10(1):190.
SHIRZADI, M. Crimean-Congo hemorrhagic fever and other viral hemorrhagic fevers. Seda publication, Tehran Iran [In Persian]. 2003.
ŠIROKÝ, P.; BĚLOHLÁVEK, T.; PAPOUŠEK, I.; JANDZIK, D.; MIKULÍČEK, P.; KUBELOVÁ, M, et al. Hidden threat of tortoise ticks: high prevalence of Crimean-Congo haemorrhagic fever virus in ticks Hyalomma aegyptium in the Middle East. Parasites & vectors. 2014;7(1):101.
SHAHHOSSEINI, N.; AZARI-GARMJAN, G.A.; REZAIYAN, M.K.; HAERI, A.; NOWOTNY, N.; FOOKS, A.R. et al. Factors Affecting Transmission of Crimean-Congo Hemorrhagic Fever among Slaughterhouse Employees: A Serosurvey in Mashhad, Iran. Jundishapur Journal of Microbiology. 2018;11(3).
SALEEM, J.; USMAN, M.; NADEEM, A.; SETHI, S.A.; SALMAN, M. Crimean–Congo hemorrhagic fever: a first case from Abbottabad, Pakistan. International Journal of Infectious Diseases. 2009;13(3):e121-e3.
SCHNEEBERGER, P.M.; HERMANS, M.H.; VAN HANNEN, E.J.; SCHELLEKENS, J.J.; LEENDERS, A.C.; WEVER, P.C. Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clinical and Vaccine Immunology. 2010;17(2):286-90.
PORTER, S.R.; CZAPLICKI, G.; MAINIL, J.; GUATTÉO, R.; SAEGERMAN, C. Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis. International journal of microbiology. 2011;2011.
UGHETTO E, GOURIET F, RAOULT D, ROLAIN J-M. Three years experience of real-time PCR for the diagnosis of Q fever. Clinical microbiology and infection. 2009;15:200-1.
WEBER F, MIRAZIMI A. Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis. Cytokine & growth factor reviews. 2008;19(5-6):395-404.
WHITEHOUSE CA. Crimean–Congo hemorrhagic fever. Antiviral research. 2004;64(3):145-60.
Apontamentos
- Não há apontamentos.
Visitas